The bold and innovative stem cell research building on the UCSF Parnassus campus stands as a testament to the architectural genius of Raphael Viñoly and public and private support of UCSF's pioneering program in regeneration medicine.
February 11, 2011
February 10, 2011
Acclaimed stem cell researcher Shinya Yamanaka, who is a professor of anatomy at UCSF, can add two more prestigious prizes to his already impressive resume.
January 31, 2011
Ray and Dagmar Dolby this week donated $20 million to the University of California, San Francisco to provide funding for a stem cell building on the Parnassus campus.
January 18, 2011
UCSF researchers have tackled a decade-long scientific conundrum, and their discovery is expected to lead to significant advances in using stem cells to treat genetic diseases before birth.
December 16, 2010
UCSF researchers have shown for the first time that the human fetal immune system arises from an entirely different source than the adult immune system, and is more likely to tolerate than fight foreign substances in its environment.
December 14, 2010
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified for the first time that progenitor rather than neural stem cells underly a type of glioma called oligodendroglioma.
November 17, 2010
Scientists are reporting the first direct evidence that a subtle change in the physical properties of a tissue can affect its function.
November 11, 2010
Ophir Klein wants to use stem cells to grow teeth. Because teeth are simple in comparison to large, vital organs, they may serve as a proving ground for regenerative medicine.
November 03, 2010
Scientists this week are moving into the headquarters for the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF, where they will continue to advance a field transformed by the revolutionary achievement of Shinya Yamanaka.
October 22, 2010
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.